Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-29T12:45:44.309Z Has data issue: false hasContentIssue false

depressive disorder and herpes zoster oticus: a case report

Published online by Cambridge University Press:  19 July 2023

H. Chebli*
Affiliation:
University Psychiatric Hospital Arrazi in Sale, SALE, Morocco
A. FARH
Affiliation:
University Psychiatric Hospital Arrazi in Sale, SALE, Morocco
S. belbachir
Affiliation:
University Psychiatric Hospital Arrazi in Sale, SALE, Morocco
A. ouanass
Affiliation:
University Psychiatric Hospital Arrazi in Sale, SALE, Morocco
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

The herpes zoster oticus results from the reactivation of the varicella zoster virus, a DNA virus of the Herpesviridae family with strictly human-to-human contamination, affecting the geniculate ganglion of the facial nerve. The manifestations of shingles and post-herpes signs are associated with psychiatric manifestations such as anxiety, insomnia and depressive disorder. Shingles and depressive disorder share common features, such as decreased cellular immunity and a high prevalence in the elderly

Objectives

Is there a correlation between the intensity of depression and the comorbidity of herpes zoster and depression? Is there an explanation for this association? Can adequate therapy of the infection prevent the occurrence of the depressive disorder? Does the existence of this comorbidity affect the response to antidepressants?

Methods

case report and litterature

Results

case report

Conclusions

We will try to answer these questions in this work while illustrating by the case of a patient having been touched by this comorbidity and while being based on what was published in literature.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.